Medtronic has launched the NAVIGATE trial study to support and validate superDimension electromagnetic navigation system for obtaining lung tissue biopsies from the periphery of the lungs.
The technology was listed by Medtronic executives as one of the “jewels in the Covidien crown” that motivated Medtronic’s$43b acquisition of Covidien in January